Lilly Endowment Inc.
Lilly Endowment Inc. reported 1 US-listed holding worth $104.21 billion in its 13F for the quarter ended 30 September 2026, filed 19 October 2026. Its largest: Eli Lilly & Co. (100.0%). Against the quarter before, it opened 0 positions, added to 0, trimmed 1 and sold out of 0.
Reported holdings$104.21B-3.9% on Q2 2026
Positions1as many as Q2 2026
The largest ten100.0%of its reported holdings
Latest 13FQ3 2026filed 19 October 2026
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Trimmed 1
Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held
Trimmed 1
- Eli Lilly & Co. LLY-310,000 shares · -0%
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Eli Lilly & Co. LLY | 90,066,978 | $104.21 billion | 100.00% | -310,000 |
Every US-listed position in the fund's 13F for the quarter ended 30 September 2026, by the value it reported.